Adicet Bio

ACET

Market cap $75.9M

ACET Hedge Fund Activity: Q1 2026 in Review

49 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q1 2026, worth a combined $43.7M — down 23% from $56.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ACET positions and 11 closed out — a net gain of 1 holder — while 12 added to existing stakes and 8 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $2.05M. The largest seller was Woodline Partners, cutting an estimated $2.33M.

• 49 institutional investors held Adicet Bio (ACET) as of Q1 2026, unchanged from Q4 2025.
• Funds reported $43.7M of Adicet Bio stock for Q1 2026, down 23% quarter-over-quarter.
• 12 funds opened new Adicet Bio positions in Q1 2026 and 11 closed out, a net change of +1 holder.
• The largest Adicet Bio buyer in Q1 2026 was Citadel Advisors, an estimated $2.05M added.
• The largest Adicet Bio seller in Q1 2026 was Woodline Partners, an estimated $2.33M sold.

Based on aggregated 13F filings for Q1 2026.